New Study Exposes Major Safety Issues With mRNA Jabs, Scientists Seek Moratorium
A new peer-reviewed scientific study is raising alarming questions about the safety of mRNA vaccine technology, including serious manufacturing discrepancies, adverse reactions, and unresolved questions about the long-term effects of the experimental platform.
In this episode of Conversations That Matter, The New American’s Alex Newman interviews Dr. Gerry Quinn of Ulster University and Dr. Ronan Connolly, two authors of the study published in the Journal of Toxicology, titled “Toxicological Vulnerabilities and Emerging Safety Signals in Modified mRNA Vaccine Technology: A Narrative Review of the COVID-19 Experience.”
The scientists, collaborating with others around the world through the Center for Environmental Research and Earth Sciences, reveal that manufacturing changes may have resulted in COVID-19 injections distributed to the public differing from the products originally tested in clinical trials, without adequate studies to establish comparability.
They also raise concerns about troubling safety signals involving cardiovascular complications, immune-system dysfunction, and other reported adverse events. In addition, there are major unanswered questions about where the genetic material travels in the body, how long it persists, and what proteins it produces.
With mRNA technology being developed for an expanding range of medical applications including flu shots and many other “vaccines,” the researchers warn that these unresolved concerns demand urgent investigation. Dr. Quinn goes so far as to call for an immediate moratorium on the technology pending further investigation.
Should governments halt the rollout of mRNA technology until its safety and effectiveness can be independently established? Watch this explosive episode to hear what the scientists uncovered and why they believe policymakers must act now, before more damage is done.
